The consolidation in the generic pharmaceutical industry continues
apace, with companies in the easterly reaches of Europe now getting
in on the act. Czech Republic-headquartered Zentiva has signed an
agreement to acquire 51 per cent...
Medimmune announced the signing of an agreement to acquire
Cellective Therapeutics, in a deal that furthers its strategy of
increasing new drug candidates in its specialist areas of cancer
and autoimmune diseases such as lupus and...
Pharmaceutical companies are increasingly looking to retain their
internal focus on research and development (R&D) and marketing
while outsourcing their manufacturing processes, thus fueling a
growing demand for the manufacturing...
India's largest pharmaceutical packaging company, Bilcare, is
planning to open a subsidiary in Germany, shortly after announcing
a major acquisition in the US, in a move that underlines its
Ambion and Rosetta Genomics have announced a licensing and
commercialisaton agreement to advance microRNA research. The
results will facilitate microRNA research that hails this as a
promising area in the treatment of a range of diseases.
Biotechnology firm, MorphoSys, have announced an agreement with
pharmaceutical company Shionogi, in a deal that fits into
MorphoSys' effort to expand geographically into the Japanese market
- currently the second largest individual...
Anglo-German company Evotec has reorganised its pharmaceutical
development services business by integrating its ProPharma
subsidiary, based in Scotland, into a new structure alongside its
Akzo Nobel business unit Diosynth, which specialises in the
production of complex active biopharmaceutical ingredients for the
pharmaceutical sector, has won a contract to apply its new method
for manufacturing synthetic peptides...
French drug delivery company Flamel Technologies suffered another
blow yesterday when it was revealed that TAP Pharmaceutical
Products has pulled out of deal to develop a formulation of its
big-selling gastrointestinal drug lansoprazole...